Product NDC: | 50991-814 |
Proprietary Name: | ALAHIST |
Non Proprietary Name: | Brompheniramine Maleate, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide |
Active Ingredient(s): | 4; 15; 7.5 mg/5mL; mg/5mL; mg/5mL & nbsp; Brompheniramine Maleate, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide |
Administration Route(s): | ORAL |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 50991-814 |
Labeler Name: | Poly Pharmaceuticals, Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part341 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20071227 |
Package NDC: | 50991-814-15 |
Package Description: | 12 BOTTLE in 1 TRAY (50991-814-15) > 15 mL in 1 BOTTLE |
NDC Code | 50991-814-15 |
Proprietary Name | ALAHIST |
Package Description | 12 BOTTLE in 1 TRAY (50991-814-15) > 15 mL in 1 BOTTLE |
Product NDC | 50991-814 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Brompheniramine Maleate, Phenylephrine Hydrochloride, Dextromethorphan Hydrobromide |
Dosage Form Name | LIQUID |
Route Name | ORAL |
Start Marketing Date | 20071227 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Poly Pharmaceuticals, Inc. |
Substance Name | BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE |
Strength Number | 4; 15; 7.5 |
Strength Unit | mg/5mL; mg/5mL; mg/5mL |
Pharmaceutical Classes |